OnKure (OKUR) director awarded 7,650 stock options at $4.30 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
OnKure Therapeutics director R. Michael Carruthers received a new stock option grant. On June 4, 2026, he was granted options covering 7,650 shares of Class A common stock at an exercise price of $4.30 per share.
All 7,650 option shares will vest on the earlier of June 4, 2027 or the day before OnKure’s next annual stockholder meeting, as long as he continues as a service provider through that date. After this grant, he holds options for 7,650 shares directly, with an expiration date of June 3, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Carruthers R Michael
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 7,650 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 7,650 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 7,650 options
Exercise price: $4.30 per share
Underlying shares: 7,650 shares
+3 more
6 metrics
Options granted
7,650 options
Stock Option (right to buy) granted June 4, 2026
Exercise price
$4.30 per share
Conversion/exercise price for 7,650 option shares
Underlying shares
7,650 shares
Class A Common Stock underlying the options
Options after transaction
7,650 options
Total options held following the grant
Vesting date
June 4, 2027 (or earlier trigger)
Vests earlier of June 4, 2027 or day before next annual meeting
Expiration date
June 3, 2036
Option expiration for the 7,650 granted options
Key Terms
Stock Option (right to buy), Class A Common Stock, exercise price, expiration date, +2 more
6 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion_or_exercise_price: 4.3000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-03T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
annual meeting of stockholders financial
"earlier of June 4, 2027 or the day prior to the date of the Issuer's next annual meeting of stockholders"
service provider financial
"subject to the Reporting Person continuing as a service provider through the applicable vesting date"
FAQ
What did OnKure Therapeutics (OKUR) director R. Michael Carruthers receive in this Form 4?
R. Michael Carruthers received a grant of stock options for 7,650 shares of OnKure Class A common stock. The options are compensation, not an open-market trade, and give him the right to buy shares at a fixed exercise price.
What are the key terms of the 7,650 OnKure (OKUR) stock options granted?
The grant covers 7,650 underlying Class A common shares with an exercise price of $4.30 per share. The options expire on June 3, 2036, giving a long window for potential future exercise if vesting conditions are met.
When do R. Michael Carruthers’s OnKure (OKUR) options vest?
All 7,650 option shares will vest on the earlier of June 4, 2027 or the day before OnKure’s next annual stockholder meeting. Vesting is contingent on Carruthers continuing as a service provider through the applicable vesting date.